For the quarter ending 2025-09-30, AMRX has $3,599,874K in assets. $201,249K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 201,249 | 71,544 | ||
| Restricted cash | 34,727 | 9,642 | ||
| Receivables-Nonrelated Party | 885,199 | 807,637 | ||
| Inventories | 614,500 | 608,973 | ||
| Prepaid expenses and other current assets | 101,511 | 85,304 | ||
| Receivables-Related Party | 1,292 | 1,592 | ||
| Total current assets | 1,838,478 | 1,584,692 | ||
| Property, plant and equipment, net | 434,991 | 440,327 | ||
| Goodwill | 595,945 | 597,406 | ||
| Net | 579,838 | - | ||
| In-process research and development | 8,100 | - | ||
| Intangible assets, net | 587,938 | 649,547 | ||
| Operating lease right-of-use assets-Nonrelated Party | 31,769 | 33,241 | ||
| Operating lease right-of-use assets-Related Party | 16,875 | 17,658 | ||
| Financing lease right-of-use assets-Nonrelated Party | 54,420 | 55,068 | ||
| Other assets | 39,458 | 44,849 | ||
| Total assets | 3,599,874 | 3,422,788 | ||
| Accounts payable and accrued expenses-Nonrelated Party | 731,825 | 666,817 | ||
| Current portion of liabilities for legal matters | 40,598 | 41,515 | ||
| Revolving credit facility | 0 | 290,000 | ||
| Current portion of long-term debt, net | 7,202 | 31,175 | ||
| Current portion of operating lease liabilities-Nonrelated Party | 7,985 | 8,223 | ||
| Current portion of operating lease liabilities-Related Party | 2,826 | 2,701 | ||
| Current portion of financing lease liabilities-Nonrelated Party | 3,458 | 3,307 | ||
| Accounts payable and accrued expenses-Related Party | 68,212 | 63,396 | ||
| Total current liabilities | 862,106 | 1,107,134 | ||
| Long-term debt, net | 2,566,500 | 2,146,403 | ||
| Operating lease liabilities-Nonrelated Party | 26,405 | 27,623 | ||
| Operating lease liabilities-Related Party | 15,676 | 16,441 | ||
| Financing lease liabilities-Nonrelated Party | 55,672 | 56,020 | ||
| Other long-term liabilities-Related Party | 8,587 | 15,607 | ||
| Liabilities for legal matters - long term | 74,477 | 74,477 | ||
| Other long-term liabilities-Nonrelated Party | 32,626 | 25,814 | ||
| Total long-term liabilities | 2,779,943 | 2,362,385 | ||
| Redeemable non-controlling interests | 67,780 | 65,802 | ||
| Common stock-Common Class A | 3,143 | 3,140 | ||
| Common stock-Common Class B | 0 | 0 | ||
| Additional paid-in capital | 563,363 | 554,623 | ||
| Stockholders' accumulated deficit | -570,081 | -572,450 | ||
| Accumulated other comprehensive loss | -105,883 | -97,431 | ||
| Total amneal pharmaceuticals, inc. stockholders deficiency | -109,458 | -112,118 | ||
| Non-controlling interests | -497 | -415 | ||
| Total stockholders' deficiency | -109,955 | -112,533 | ||
| Total liabilities and stockholders deficiency | 3,599,874 | 3,422,788 | ||
Amneal Pharmaceuticals, Inc. (AMRX)
Amneal Pharmaceuticals, Inc. (AMRX)